Nuvalent (NUVL) Earnings Date & Reports

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NUVL is expected to report earnings to rise 7.62% to -112 cents per share on May 08

Q1'25

Est.

$-1.13

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.34

Q2'24

Missed

by $0.12

Q1'24

Missed

by $0.03

The last earnings report on February 27 showed earnings per share of -104 cents, beating the estimate of -108 cents. With 478.93K shares outstanding, the current market capitalization sits at 4.89B.

View a ticker or compare two or three

Compare

NUVL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NUVL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NUVL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Broadway

Phone

+1 857 357-7000

Employees

Web

https://www.nuvalent.com